A-to-I RNA Editing: An Overlooked Source of Cancer Mutations

Cancer Cell
Shay Ben-Aroya, Erez Y Levanon

Abstract

RNA editing is a source of transcriptomic diversity, mainly in non-coding regions, and is found to be altered in cancer. In this issue of Cancer Cell, Peng et al. show that RNA editing events are manifested at the proteomic levels and are a source of cancer protein heterogeneity.

Citations

Sep 25, 2019·Journal of Translational Medicine·Theodoulakis Christofi, Apostolos Zaravinos
Oct 15, 2019·Genomics & Informatics·Jiyeon Park, Yeun-Jun Chung
Dec 29, 2020·Frontiers in Oncology·Chi ZhouQi Liu
Sep 9, 2019·Trends in Molecular Medicine·Chi ZhouQi Liu
Dec 10, 2021·PloS One·Knud Larsen, Mads Peter Heide-Jørgensen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Related Papers

Rinshō shinkeigaku = Clinical neurology
Shin Kwak
Postepy biochemii
C Zekanowski
Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme
S Yamanaka, H Iwao
Frontiers of Hormone Research
K A HollandN Navaratnam
© 2022 Meta ULC. All rights reserved